Related references
Note: Only part of the references are listed.Correlation of plasma concentration and adverse effects of bosutinib: standard dose or dose-escalation regimens of bosutinib treatment for patients with chronic myeloid leukemia
Akiko Mita et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2018)
Effect of bosutinib on the absorption of dabigatran etexilate mesylate, a P-glycoprotein substrate, in healthy subjects
Poe-Hirr Hsyu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib
Richat Abbas et al.
CLINICAL PHARMACOKINETICS (2016)
In vitro and in vivo identification of ABCB1 as an efflux transporter of bosutinib
Sara Redaelli et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemia
Chiaki Nakaseko et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2015)
Pregnane X receptor upregulates ABC-transporter Abcg2 and Abcb1 at the blood-brain barrier
Julia Lemmen et al.
BRAIN RESEARCH (2013)
Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
Jorge E. Cortes et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
Jorge E. Cortes et al.
BLOOD (2011)
Gestational and Pregnane X Receptor-Mediated Regulation of Placental ATP-Binding Cassette Drug Transporters in Mice
Sarabjit S. Gahir et al.
DRUG METABOLISM AND DISPOSITION (2011)
Effect of Ketoconazole on the Pharmacokinetics of Oral Bosutinib in Healthy Subjects
Richat Abbas et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin
Yuan Gao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients
Masatomo Miura et al.
STEROIDS (2008)
MDR1 gene polymorphisms and risk of recurrence in patients with hepatocellular carcinoma after liver transplantation
Liming Wu et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease
MM Dring et al.
GASTROENTEROLOGY (2006)
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
D Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2005)
Genetic polymorphisms influencing xenobiotic metabolism and transport in patients with primary biliary cirrhosis
Y Kimura et al.
HEPATOLOGY (2005)
Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor
JM Rosenfeld et al.
MOLECULAR ENDOCRINOLOGY (2003)
The nuclear pregnane X receptor: A key regulator of xenobiotic metabolism
SA Kliewer et al.
ENDOCRINE REVIEWS (2002)
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants
J Zhang et al.
PHARMACOGENETICS (2001)
Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
I Cascorbi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2001)
Acute myelogenous leukemia with PIG-A gene mutation evolved from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome
H Tanaka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2001)
Share Paper
